carbachol has been researched along with Parkinsonian Disorders in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blazer, LL | 1 |
| Storaska, AJ | 1 |
| Jutkiewicz, EM | 1 |
| Turner, EM | 1 |
| Calcagno, M | 1 |
| Wade, SM | 1 |
| Wang, Q | 1 |
| Huang, XP | 1 |
| Traynor, JR | 1 |
| Husbands, SM | 1 |
| Morari, M | 1 |
| Neubig, RR | 1 |
| McCarthy, MM | 1 |
| Moore-Kochlacs, C | 1 |
| Gu, X | 1 |
| Boyden, ES | 1 |
| Han, X | 1 |
| Kopell, N | 1 |
2 other studies available for carbachol and Parkinsonian Disorders
| Article | Year |
|---|---|
Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors.
Topics: Animals; Antiparkinson Agents; Bradycardia; Calcium; Carbachol; Cell Line, Tumor; Cholinergic Agonis | 2015 |
Striatal origin of the pathologic beta oscillations in Parkinson's disease.
Topics: Action Potentials; Animals; Beta Rhythm; Carbachol; Cholinergic Agonists; Dopamine; gamma-Aminobutyr | 2011 |